We promote drug discovery not only through collaborations with various players in the drug discovery eco-system (universities, pharmaceutical companies, investors, government, CROs, CMOs), but also by leading those collaborations.
Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales.
